What is the ICD-10 (International Classification of Diseases, 10th Revision) code for albuterol (beta-2 adrenergic agonist)-ipratropium (anticholinergic) nebulized solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code Clarification

There is no ICD-10 code for albuterol-ipratropium nebulized solution itself, as ICD-10 codes classify diagnoses and medical conditions, not medications or treatments.

Understanding ICD-10 vs. Other Coding Systems

  • ICD-10 (International Classification of Diseases, 10th Revision) is used exclusively for coding diagnoses, symptoms, and medical conditions—not medications, procedures, or treatments 1

  • For coding the medication albuterol-ipratropium, you would need:

    • NDC (National Drug Code) for the specific drug product
    • HCPCS codes for billing nebulizer treatments (e.g., J7620 for albuterol and ipratropium combined)

What You Likely Need Instead

If coding the underlying condition being treated:

  • J44.1 - Chronic obstructive pulmonary disease with acute exacerbation 1
  • J45.901 - Unspecified asthma with acute exacerbation 1
  • J45.51 - Severe persistent asthma with status asthmaticus 1

If coding the administration procedure:

  • 94640 - CPT code for pressurized or nonpressurized inhalation treatment for acute airway obstruction
  • J7620 - HCPCS code for albuterol and ipratropium bromide, inhalation solution administered through DME, concentrated form, per mg

Clinical Context for Appropriate Diagnosis Coding

  • The combination of albuterol-ipratropium is indicated for severe asthma exacerbations (FEV1 or PEF <40% predicted) or moderate-to-severe COPD exacerbations, which would guide your ICD-10 diagnosis code selection 1

  • For acute severe asthma requiring combination bronchodilator therapy, use J45.901 or J45.51 depending on severity 1

  • For COPD patients requiring combination therapy, J44.1 is appropriate when treating an acute exacerbation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the recommended dosage and treatment regimen for the combination of ipratropium (Ipratropium bromide) and albuterol (Albuterol sulfate) in patients with Chronic Obstructive Pulmonary Disease (COPD) or asthma?
What is the recommended frequency of ipratropium (Ipratropium) and albuterol (Albuterol) versus albuterol (Albuterol) alone for Chronic Obstructive Pulmonary Disease (COPD) treatment?
What is the recommended dosing regimen for albuterol (beta2-adrenergic agonist) and ipratropium (anticholinergic) combination for the treatment of Chronic Obstructive Pulmonary Disease (COPD) or asthma?
What is a DuoNeb (ipratropium bromide and albuterol sulfate)?
What is the dosing regimen for ipratropium bromide (IPR) and albuterol (ALB) in combination for patients with respiratory conditions?
Why is a strict liquid diet recommended for patients undergoing maxillomandibular fixation (MMF) for facial fractures?
How does diabetes cause autonomic neuropathy in patients with long-standing diabetes?
What is the treatment of choice for a patient with hyponatremia, hyperkalemia, and hypochloremia?
What is the management for a patient with low Pulmonary Artery Pulsatility Index (PAPi), high Central Venous Pressure (CVP), mean Pulmonary Artery Pressure (mPAP), and Pulmonary Artery Diastolic Pressure (PADP), but normal Cardiac Output (CO), Cardiac Index (CI), and mixed Venous Oxygen Saturation (SvO2)?
What is the role of Open Reduction Internal Fixation (ORIF) in treating a patient with a complex or unstable facial fracture?
What is the recommended dose and administration of glimepiride (sulfonylurea) and metformin (biguanide) for a typical adult patient with type 2 diabetes mellitus (DM)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.